Impact Biomedicines

Impact Biomedicines

Impact Biomedicines

Impact Biomedicines is pioneering the development of life changing treatments for patients with complex cancers.
Founded
2016
Raised
$22M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$22,000,000
Venture capital (Series A) - 2017
Medicxi Ventures Oberland Capital
Team Size
2
Employees
PE HUB , Bloomberg

| Celgene to buy Impact Biomedicines for up to $7 billion: Reuters

Health Earnings